Lupin Limited (Lupin) has formed a unique partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a pioneer in cheap pharmaceuticals, and the COPD Foundation, which is dedicated to improving the lives of COPD sufferers....
Fujifilm India, a pioneer in healthcare imaging and information systems formalized their partnership with department of gastroenterology, Yashoda Group of Hospitals, Hyderabad for establishing training and research facility...
According to Poonam Khetrapal Singh, Regional Director, World Health Organisation (WHO) South-East Asia, India's G20 presidency has identified three health priorities: strengthening global health infrastructure, delivering health, and providing...
Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders...
Cytecare Hospitals, one of India's healthcare leaders, has launched a state-of-the-art Nephrology Institute in collaboration with Humanist Centre for Medicine (Humanist), a Bengaluru-based NGO that aims to bridge funding gaps for patients....
In an effort to address the concerns raised from time to time regarding the quality, safety and efficacy of the drugs and uniform implementation of the provisions of the regulations, the central drug regulator has been contemplating a comprehensive..
A significant business delegation from the Nigerian pharmaceutical industry is set to engage in discussions with Indian manufacturers and exporters in New Delhi from September 5 to 10, 2023, with the aim of forging potential joint ventures...
Pharmaceutical companies are poised to sustain their growth and profitability, with the United States playing a central role in their expansion, reports India Ratings and Research (Ind-Ra). The industry's upward trajectory will be fueled by product..
Cipla South Africa, a division of Cipla Limited, has agreed to buy Actor Pharma, a prominent player in the South African over-the-counter (OTC) market, in order to increase its presence in the country's healthcare sector...
AstraZeneca’s Calquence , a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)...
, CDSCO.jpg)
